Drug recall · September 30, 2020
Red-E Tablet recall
Why: Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling.
- Lots / codes
All lots.
- Quantity
- 21,511 tablets
- Company
- The Protein Shoppe, Pharr, TX
- Distribution
- Nationwide in the USA
- Initiated
- September 1, 2020 · Voluntary: Firm initiated
- Classified
- September 24, 2020
- Reported
- September 30, 2020
- Ended
- February 8, 2022
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.